| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.32B | 94.08B | 89.79B | 83.76B | 83.98B | 75.50B |
| Gross Profit | 17.96B | 21.06B | 17.27B | 14.90B | 15.13B | 14.69B |
| EBITDA | 9.74B | 10.90B | 8.98B | 7.04B | 6.81B | 6.57B |
| Net Income | 6.43B | 8.68B | 5.91B | 4.80B | 4.64B | 4.37B |
Balance Sheet | ||||||
| Total Assets | 91.29B | 110.94B | 99.92B | 98.23B | 94.69B | 87.47B |
| Cash, Cash Equivalents and Short-Term Investments | 30.53B | 34.38B | 26.77B | 31.95B | 29.93B | 33.96B |
| Total Debt | 2.13B | 14.00M | 17.00M | 7.00M | 13.00M | 21.00M |
| Total Liabilities | 20.05B | 30.26B | 28.23B | 28.31B | 29.97B | 24.05B |
| Stockholders Equity | 70.22B | 79.58B | 70.68B | 68.92B | 63.75B | 61.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.52B | -847.00M | 3.92B | 911.00M | 1.60B |
| Operating Cash Flow | 0.00 | 11.64B | -616.00M | 4.17B | 1.12B | 1.70B |
| Investing Cash Flow | 0.00 | 1.40B | -1.79B | 244.00M | -2.55B | -269.00M |
| Financing Cash Flow | 0.00 | -4.43B | -3.77B | -3.38B | -3.60B | -2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥132.65B | 8.69 | ― | 2.81% | 5.14% | 18.79% | |
79 Outperform | ¥146.84B | 13.90 | ― | 3.22% | 14.62% | 33.65% | |
79 Outperform | ¥131.84B | 15.51 | ― | 2.14% | 4.78% | 50.65% | |
77 Outperform | ¥94.53B | 12.33 | ― | 4.38% | -6.07% | 44.83% | |
65 Neutral | ¥109.34B | 10.97 | ― | 2.13% | 3.17% | 77.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥80.17B | 9.55 | ― | 3.63% | 20.40% | 50.00% |